Arteris AIP 深 沪
交易中 10-22 11:37:41 美东时间
19.2102
-1.720
-8.22%
华盛通- 最 高20.12
- 今 开20.12
- 成交量 13.58万股
- 最 低 18.915
- 昨 收 20.93
- 总市值 9.44亿
- 52周最高 50.26
- 市盈率 静 --
- 换手率 0.28%
- 52周最低 12.06
- 委 比 85.19%
- 总股本 4915.21万
- 历史最高 50.26
- 量 比 0.70
- 振 幅 5.76%
- 历史最低 3.27
- 每 手 1
- 风险率 8.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Arteris Announces Expansion Of Third-Party IP Security Assurance Program In Collaboration With BAE Systems And SiFive
Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced the expansion of its third-party IP (3PIP) security assurance program in collaboration with BAE Systems and SiFive, Inc. This program has received an additional $3.3 ...
10-06 21:04
Arteris Wins Funding to Expand Hardware Design Supply Chain Security Assurance for the Trusted and Assured Microelectronics Program
Arteris, BAE Systems, and SiFive expand their third-party IP security assurance program with $3.3 million funding from the U.S. government's T&AM program. The initiative aims to enhance security methodologies for mission-critical semiconductor systems, particularly in aerospace and defense. The collaboration focuses on developing repeatable, evidence-based processes to ensure the trustworthiness of commercially sourced IP integrated into advanced...
10-06 13:00
美股大行评级 | 麦当劳目标价遭下调至320美元！现价仍有近3成上涨空间；戴尔、迈威尔、微软齐获机构看好
今日重点评级关注：HC Wainwright & Co.：维持Gossamer Bio"买入"评级，目标价从2美元升至90美元；巴克莱：维持Ultragenyx Pharmaceutical"超配"评级，目标价从32美元升至35美元
09-22 16:25
Craig-Hallum Initiates Coverage On Arteris with Buy Rating, Announces Price Target of $30
Craig-Hallum analyst Anthony Stoss initiates coverage on Arteris (NASDAQ:AIP) with a Buy rating and announces Price Target of $30.
09-22 01:44
Arteris Announces New Employment Inducement Grants
Arteris, Inc. granted equity awards to its CFO, Saurabh Sinha, under its 2022 Employment Inducement Incentive Plan. The awards include RSUs worth $3.7 million (142,835 shares) and PSUs worth $1 million (38,604 shares). RSUs vest over four years, with 25% after the first year and the rest quarterly. PSUs vest upon achieving $200 million revenue by 2030 and a stock price of $65 by 2031. If a change in control occurs before performance goals are met...
09-11 20:30
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
Arteris Q2 Adj. EPS $(0.10) Misses $(0.04) Estimate, Sales $24.134M Beat $23.482M Estimate
Arteris (NASDAQ:AIP) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.04) by 150 percent. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $24.134 million which be...
08-07 04:13
Arteris 2026年第二季度财报：营收增46%，亏损继续扩大
Arteris 2026年第二季度营收2410万美元，同比增长46%；每股亏损0.30美元，自由现金流转正至862万美元。ACV加版税达9950万美元，但费用上升令亏损扩大。
08-07 01:18
Arteris appoints Saurabh Sinha as CFO
Arteris (AIP) on Thursday announced the appointment of Saurabh Sinha as Chief Financial Officer, effective September 8, 2026. Sinha succeeds Nick Hawkins, who is retiring after seven years with the c...
08-06 20:57
美股大行评级 | Palantir、Snap、爵士制药获多家大行上调目标价；潜在涨幅176.34%！巴克莱维持Snap(SNAP)"超配"评级，目标价从15美元上调至16美元
今日重点评级关注：巴克莱：维持Snap"超配"评级，目标价从15美元升至16美元；Canaccord Genuity：维持阿梅雷斯克"买入"评级，目标价从59美元升至62美元
08-05 11:45
